BIOI mentioned in here:
****
"Biotech Stocks: Boom or Bust?" Experts Help Investors Analyze Biotechs At Investors Forum June 6 In Bethesda
BETHESDA, Md.--(BUSINESS WIRE)--June 1, 1998--Recent investor focus on biotechnology companies involved in potential cancer cures obscure perhaps better current opportunities available in other biotechnology stocks, a prominent industry researcher said today.
Dr. Alex Arrow, Vice President/Research at Los Angeles-based Wedbush Morgan Securities, is the opening keynote speaker at the First Annual Beltway Biotech Stocks Forum Saturday June 6 at the Hyatt Regency Bethesda. The closing keynote speaker is Kris Jenner, M.D., Ph.D., BioPharma Analyst at T. Rowe Price Associates (NASDAQ:TROW) of Baltimore. The Forum runs from 8:30 a.m.-1 p.m. Breakfast is served beginning at 7:30.
In addition to the two featured speakers, attendees will hear full analyst-style presentations from top executives of seven biotech companies including EntreMed Inc. (NASDAQ:ENMD), CytRx (NASDAQ:CYTR), Gene Logic (NASDAQ:GLGC), Integra Life Sciences (NASDAQ:IART), SunPharm (NASDAQ:SUNP) Boston Life Sciences (NASDAQ:BLSI) and OSI Pharmaceuticals (NASDAQ:OSIP). Executives will give 20-25 minute presentations, followed by question-and-answer period.
The cost is $25 prepaid (by 5 p.m. June 4) and $40 at the door. Call Informed Investors at 800/992-4683 to register. Audio tapes are available for $45 plus $3.95 S/H which includes all company presentations plus keynote speakers. Visit informedinvestors.com for more information.
Arrow cites wound healing as a biotech sector under-appreciated by investors. Two companies, for example, Organogenesis (AMEX:ORG) and Advanced Tissue Sciences (NASDAQ:ATIS), are manufacturing artificial skin that have market opportunities in treating chronic skin ulcers and burns, among other uses. Each has at least one product already approved by the FDA and other treatments are under development.
Another company, Closure Medical (NASDAQ:CLSR), has developed a safe and effective alternative to topical sutures used in the closure of certain incisions and lacerations. Sealants are sometimes preferable to sutures because they work faster, don't involve needles and don't require a second visit to remove sutures, Arrow said. Fewer visits mean lower costs.
Biologically-engineered interior wound surgical sealants is another biotech area that holds promise, Arrow said. Focal, Inc. (NASDAQ:FOCL), for example, is developing products for use inside the body with or without sutures and staples to seal leaks resulting from pulmonary surgery, neurosurgery, cardiovascular, and gastrointestinal surgery.
Another sector underfollowed by the investment community, Arrow said, are companies providing biomedical research supplies/services. "Several of these companies are already profitable and don't have the FDA-related exposure most biotech companies face," Arrow said. BioSource (NASDAQ:BIOI) and Biosite Diagnostics (NASDAQ:BSTE) are two profitable companies in this sector that are already profitable, Arrow said.
Companies Arrow currently follows include Advanced Tissue Sciences Avigen (NASDAQ:AVGN), BioSource International, Biosite Diagnostics, Gentle Dental Service Corp. (NASDAQ:GNTL), I-Flow (NASDAQ:IFLO), Integra LifeSciences, Life Medical Sciences (NASDAQ:CHAI), Ortec International (NASDAQ:ORTC), Vista Medical Technologies (NASDAQ:VMTI) and Zevex International (AMEX:ZVX).
Informed Investors is highly regarded for showcasing fast-growing technology and biotechnology companies at its Forums. Companies scheduled to present at upcoming biotech-related forums in 1998 include Sugen (NASDAQ:SUGN), AXYS Pharmaceuticals (NASDAQ:AXPH), Chiron (NASDAQ:CHIR), Megabios (NASDAQ:MBIO), Shaman Pharmaceuticals (NASDAQ:SHMN), Genentech (NYSE:GNE), La Jolla Pharmaceutical (NASDAQ:LJPC), BioSource, Cytel (NASDAQ:CYTL), Alliance Pharmaceuticals (NASDAQ:ALLP), Xoma (NASDAQ:XOMA), OxiGene (NASDAQ:OXGN), Corixa (NASDAQ:CRXA) and Immunex (NASDAQ:IMNX).
Since 1993, Informed Investors has featured scores of quality companies and industry experts at its Forums specializing particularly in technology and biotechnology. Informed Investors represents individual investors who collectively hold an estimated $2 billion in investable assets.
CONTACT:
Informed Investors
Carol Short/Steve Chanecka or Sean Finnigan,
916/448-8222 or 800/992-4683
KEYWORD: MARYLAND CALIFORNIA
BW0336 JUN 01,1998
|
